Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
HENRY SCHEIN INC | Director | Common Stock, par value $0.01 per share | 8.16K | $624K | $76.50 | Mar 4, 2024 | Direct |
Adverum Biotechnologies, Inc. | Director | Stock Option (Right to Buy) | 10.5K | Jun 17, 2024 | Direct | ||
CTI BIOPHARMA CORP | Director | Common Stock | 0 | $9.10 | Jun 26, 2023 | Direct | |
CTI BIOPHARMA CORP | Director | Stock Option (Right to Buy) | 0 | Jun 26, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ADVM | Adverum Biotechnologies, Inc. | Jun 17, 2024 | 1 | $0 | 4 | Jun 20, 2024 | Director |
HSIC | HENRY SCHEIN INC | Mar 1, 2024 | 2 | -$38.1K | 4 | Mar 5, 2024 | Director |
CTIC | CTI BIOPHARMA CORP | Jun 26, 2023 | 8 | -$443K | 4 | Jun 26, 2023 | Director |
ADVM | Adverum Biotechnologies, Inc. | Jun 9, 2023 | 1 | $0 | 4 | Jun 13, 2023 | Director |
CTIC | CTI BIOPHARMA CORP | Apr 5, 2023 | 1 | $0 | 4 | Apr 7, 2023 | Director |
HSIC | HENRY SCHEIN INC | Mar 16, 2023 | 1 | -$34.9K | 4 | Mar 17, 2023 | Director |
HSIC | HENRY SCHEIN INC | Mar 1, 2023 | 1 | $0 | 4 | Mar 3, 2023 | Director |
CTIC | CTI BIOPHARMA CORP | Dec 31, 2022 | 1 | $0 | 5 | Feb 14, 2023 | Director |
ADVM | Adverum Biotechnologies, Inc. | Jun 10, 2022 | 1 | $0 | 4 | Jun 14, 2022 | Director |
HSIC | HENRY SCHEIN INC | Mar 16, 2022 | 1 | $0 | 4 | Mar 18, 2022 | Director |
CTIC | CTI BIOPHARMA CORP | Mar 9, 2022 | 1 | $0 | 4 | Mar 11, 2022 | Director |
HSIC | HENRY SCHEIN INC | Jun 11, 2021 | 1 | $0 | 4 | Jun 15, 2021 | Director |
HSIC | HENRY SCHEIN INC | May 13, 2021 | 0 | $0 | 3 | May 19, 2021 | Director |